LSO Webinar: Maximizing Value of Cannabis-Based Medicine
January 21 @ 9:00 am - 10:00 am
There is a growing body of evidence more conclusively demonstrating the medical benefits of cannabis. Yet, the full potential of these products are not being realized in part because of a lack of rigorous clinical evidence and careful consideration of product attributes that can distinguish specific cannabis-based pharmaceuticals.
The panel will discuss what the industry can do to further shift the sentiment among the medical community and patients and ultimately deliver enhanced health benefits.
- David Berg, President and Chief Technology Officer at Strainprint
- Chris Delvecchio, Principal, Shift Health
- Jeremey Desai, Director and CEO of Madara Pharma